Marker Therapeutics, Inc. (MRKR)
USD 4.03
(-17.08%)
USD 4.03
(-17.08%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -16.43 Million | -26.97 Million | -27.27 Million | -18.85 Million | -18.28 Million | -14.47 Million |
| Net Income | -14.04 Million | -29.93 Million | -41.87 Million | -28.7 Million | -21.42 Million | -147.95 Million |
| Depreciation & Amortization | - | 3.68 Million | 3.16 Million | 1.07 Million | 286.58 Thousand | - |
| Deferred income taxes | - | - | -7.14 Million | - | - | - |
| Stock-based compensation | 858.26 Thousand | 3.3 Million | 5.96 Million | 5.22 Million | 5.35 Million | 16.35 Million |
| Change in working capital | 2.84 Million | -5.81 Million | 5.47 Million | 3.57 Million | -2.48 Million | 1.04 Million |
| Other non-cash items | -6.09 Million | -252.68 Thousand | 7.14 Million | -31 Thousand | -18 Thousand | 116.08 Million |
| Investing Cash Flow | 18.66 Million | -4.94 Million | -3.13 Million | -10.42 Million | -374.98 Thousand | -147.66 Thousand |
| Investments in PPE | 1.00 | -4.94 Million | -3.13 Million | -10.42 Million | -374.98 Thousand | -147.66 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 18.66 Million | -4.94 Million | -1.55 Million | -6.78 Million | - | - |
| Financing Cash Flow | 1.1 Million | 202.13 Thousand | 52.55 Million | 6.73 Million | 816.47 Thousand | 71.24 Million |
| Debt repayment | - | -513.89 Thousand | -388.79 Thousand | -173.26 Thousand | -185.17 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -71.71 Thousand |
| Common Stock Issuance | 1.1 Million | 202.13 Thousand | 52.55 Million | 6.18 Million | 816.47 Thousand | 66.94 Million |
| Other Financing Activities | 90.47 Thousand | 513.89 Thousand | 391.87 Thousand | 723.26 Thousand | 185.17 Thousand | 4.37 Million |
| Accounts receivables | 1.37 Million | -2.4 Million | 1 Million | 55.63 Thousand | 51.98 Thousand | - |
| Accounts payables | 611.26 Thousand | -4.3 Million | 4.14 Million | 4.22 Million | -963.96 Thousand | 1.24 Million |
| Inventory | - | 2.4 Million | -1 Million | -55.63 Thousand | -51.98 Thousand | - |
| Other working capital | 861.11 Thousand | -1.51 Million | 1.33 Million | -649.12 Thousand | -1.51 Million | -198.74 Thousand |
| Cash at beginning of period | 11.78 Million | 43.49 Million | 21.35 Million | 43.9 Million | 61.74 Million | 5.12 Million |
| Cash at end of period | 15.11 Million | 11.78 Million | 43.49 Million | 21.35 Million | 43.9 Million | 61.74 Million |
| Capital Expenditure | 1.00 | -4.94 Million | -3.13 Million | -10.42 Million | -374.98 Thousand | -147.66 Thousand |
| Effect of forex changes on cash | -6.09 Million | - | - | - | - | - |
| Net cash flow / Change in cash | 3.32 Million | -31.71 Million | 22.14 Million | -22.55 Million | -17.84 Million | 56.61 Million |
| Free Cash Flow | -16.43 Million | -31.91 Million | -30.41 Million | -29.28 Million | -18.65 Million | -14.62 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.19 Million | -2.39 Million | -14.04 Million | -2.74 Million | -2.98 Million | -3.35 Million |
| Depreciation & Amortization | - | - | - | -971.73 Thousand | - | - |
| Deferred income taxes | - | - | - | 2.53 Million | - | - |
| Stock-based compensation | 62.6 Thousand | 79.41 Thousand | 858.26 Thousand | 143.37 Thousand | 175.04 Thousand | -120.05 Thousand |
| Change in working capital | -1.43 Million | -1.52 Million | 2.84 Million | 292.11 Thousand | 1.93 Million | 3.16 Million |
| Other non-cash items | 971.31 Thousand | 698.55 Thousand | -6.09 Million | -62.93 Thousand | -260.28 Thousand | -6.74 Million |
| Investing Cash Flow | - | - | 18.66 Million | -18.66 Million | 18.66 Million | 18.77 Million |
| Investments in PPE | - | - | - | - | - | 112.6 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 18.66 Million | -18.66 Million | 18.66 Million | 18.66 Million |
| Financing Cash Flow | 44.6 Thousand | 49.09 Thousand | 1.1 Million | 5135.00 | 479.27 Thousand | 736.00 |
| Debt repayment | - | - | - | -255.6 Thousand | - | -127.8 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 44.6 Thousand | 49.09 Thousand | 1.1 Million | 5135.00 | 394.66 Thousand | 736.00 |
| Other Financing Activities | 7704.00 | 49.09 Thousand | 90.47 Thousand | 5135.00 | 84.6 Thousand | 127.8 Thousand |
| Accounts receivables | -638.68 Thousand | -823.64 Thousand | 1.37 Million | -944.5 Thousand | 1.66 Million | 336.78 Thousand |
| Accounts payables | -270.02 Thousand | 204.5 Thousand | 611.26 Thousand | 402.91 Thousand | 11.31 Thousand | 447.04 Thousand |
| Inventory | - | - | - | 191.31 Thousand | - | 127.8 Thousand |
| Other working capital | -528.78 Thousand | -904.57 Thousand | 861.11 Thousand | 833.69 Thousand | 265.63 Thousand | 2.25 Million |
| Cash at beginning of period | 11.32 Million | 15.11 Million | 11.78 Million | 17.47 Million | 18.12 Million | 6.4 Million |
| Cash at end of period | 7.8 Million | 11.32 Million | 15.11 Million | 15.11 Million | 17.47 Million | 18.12 Million |
| Capital Expenditure | - | - | - | - | - | 112.6 Thousand |
| Effect of forex changes on cash | - | - | -6.09 Million | -9.31 Million | 1.74 Million | 7.56 Million |
| Net cash flow / Change in cash | -3.52 Million | -3.78 Million | 3.32 Million | -2.36 Million | -648.18 Thousand | 11.72 Million |
| Free Cash Flow | -3.56 Million | -3.83 Million | -16.43 Million | -2.36 Million | -1.12 Million | -6.94 Million |
5250
EGFEY
7181
6556
MODEL-B
MSAI